Antitrust Antitrust

Vyera executives probed by US FTC on exclusionary deals, company control on first day of 'Pharma Bro' trial

By Max Fillion
  • 14 Dec 2021 20:24
  • 15 Dec 2021 09:27
Past and current Vyera Pharmaceuticals executives were probed by a US Federal Trade Commission attorney about the company’s 2016 deal with the Japanese maker of a key Daraprim ingredient, on the first day of trial for state and federal governments’ monopolization suits against “Pharma Bro” Martin Shkreli, the company's co-founder and former

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News